Blue Edge Capital’s Amgen AMGN Stock Holding History

Blue Edge Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$621K	Sell	1,714 -400	-19%	-$137K	0.07%	93
2026 Q1	$744K	Buy	2,114 +4	+0.2%	+$1.43K	0.1%	87
2025 Q4	$691K	Buy	2,110 +377	+22%	+$120K	0.09%	88
2025 Q3	$489K	Hold	1,733	–	–	0.07%	94
2025 Q2	$484K	Hold	1,733	–	–	0.07%	91
2025 Q1	$540K	Hold	1,733	–	–	0.09%	86
2024 Q4	$452K	Hold	1,733	–	–	0.07%	91
2024 Q3	$558K	Hold	1,733	–	–	0.09%	85
2024 Q2	$541K	Hold	1,733	–	–	0.09%	86
2024 Q1	$493K	Hold	1,733	–	–	0.08%	90
2023 Q4	$499K	Buy	1,733 +400	+30%	+$109K	0.09%	83
2023 Q3	$358K	Hold	1,333	–	–	0.08%	90
2023 Q2	$296K	Hold	1,333	–	–	0.06%	91
2023 Q1	$322K	Hold	1,333	–	–	0.07%	92
2022 Q4	$350K	Hold	1,333	–	–	0.08%	94
2022 Q3	$300K	Hold	1,333	–	–	0.07%	92
2022 Q2	$324K	Hold	1,333	–	–	0.08%	91
2022 Q1	$322K	Hold	1,333	–	–	0.06%	95
2021 Q4	$300K	Hold	1,333	–	–	0.06%	92
2021 Q3	$283K	Hold	1,333	–	–	0.06%	89
2021 Q2	$325K	Hold	1,333	–	–	0.07%	94
2021 Q1	$332K	Hold	1,333	–	–	0.07%	85
2020 Q4	$306K	Hold	1,333	–	–	0.07%	89
2020 Q3	$339K	Hold	1,333	–	–	0.09%	81
2020 Q2	$314K	Hold	1,333	–	–	0.09%	81
2020 Q1	$270K	Buy	+1,333	New	+$291K	0.1%	85

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Blue Edge Capital's AMGN Position: Q2 2026 in Review

Blue Edge Capital reduced its Amgen (AMGN) stake by 19% in Q2 2026, selling an estimated $137K and leaving 1,714 shares worth $621K. The position accounts for 0.07% of the portfolio, ranked #93.

Blue Edge Capital first reported a position in AMGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $744K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Blue Edge Capital held 1,714 shares of Amgen worth $621K as of Q2 2026.
Blue Edge Capital sold 400 Amgen shares in Q2 2026, an estimated $137K.
Amgen made up 0.07% of Blue Edge Capital's portfolio in Q2 2026, its #93 holding.
Blue Edge Capital first reported a position in Amgen in Q1 2020 and has held it in 26 quarters since.
Blue Edge Capital's Amgen position peaked at $744K in Q1 2026.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Blue Edge Capital's 13F filing for Q2 2026, filed 17 Aug 2026.